Providers/Grant Support
Provided by Association of Cancer Care Centers.
This activity is supported by an educational grant from Genentech.
Credits Available
All healthcare professionals will receive a certificate of participation for completing the course.
Target Audience
This activity is designed to meet the educational needs of members of the multidisciplinary CLL care team: Oncologists/heme oncologists, oncology APPs (NPs, pharmacists, PAs), oncology nurses, oncology navigators, oncology clinical social workers, and other members of the cancer care team who are involved with care for patients with CLL.
Program Overview
This activity will highlight new treatment options for CLL, best practices, shared decision-making, and incorporating patient preferences into treatment decisions.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss new therapeutic options (with an emphasis on oral/oral combination therapies), including treatment initiation and management, lab monitoring, patient logistics, and how these new options may impact the patient experience
- Help providers garner a better understanding of patient preferences around fixed duration vs. treat-to-progression regimens
- Review best practices in shared decision making (SDM) around fixed duration vs. treat-to-progression and key issues to be discussed in the SDM process (eg, patient preferences, costs, travel/transportation)
- Discuss the benefits of being off CLL treatment when receiving covid vaccines (share data showing this potentially leads to stronger immune response/antibody formation/immune protection)
Faculty
Christine Helou, MSN, FNP-BC, OCN
Oncology Nurse Practitioner
Virginia Cancer Specialists
Fairfax, VA
Jose Sandoval Sus, MD, FACP
Hematologic Oncologist, Associate Member
Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System
Pembroke Pines, FL
Adam Kittai, MD
Associate Professor of Medicine
Assistant Director of Lymphoma Clinical Research
Mount Sinai
New York, NY
Jeff Sharman, MD
Medical Oncologist, Hematologist
Willamette Valley Cancer Institute
Eugene, OR
Instructions for Participation and Credit
There are no fees for participating in this enduring activity. To receive certification of completion participants must:
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Desktop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]